Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Condition:   T2DM Interventions:   Drug: Chiglitazar;   Drug: Empagliflozin;   Drug: Atorvastatin;   Drug: Valsartan Sponsor:   Chipscreen Biosciences, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials